Register

Login

Vet Times logo
+
  • View all news
  • Vets news
  • Vet Nursing news
  • Business news
  • + More
    • Videos
    • Podcasts
    • Crossword
  • View all clinical
  • Small animal
  • Livestock
  • Equine
  • Exotics
  • All Jobs
  • Your ideal job
  • Post a job
  • Career Advice
  • Students
About
Contact Us
For Advertisers
NewsClinicalJobs
Vet Times logo

Vets

All Vets newsSmall animalLivestockEquineExoticWork and well-beingInternational

Vet Nursing

All Vet Nursing newsSmall animalLivestockEquineExoticWork and well-beingOpinion

Business

All Business newsHuman resourcesBig 6SustainabilityFinanceDigitalPractice profilesPractice developments

+ More

VideosPodcastsDigital EditionCrossword

The latest veterinary news, delivered straight to your inbox.

Choose which topics you want to hear about and how often.

Vet Times logo 2

About

The team

Advertise with us

Recruitment

Contact us

Vet Times logo 2

Vets

All Vets news

Small animal

Livestock

Equine

Exotic

Work and well-being

International

Vet Nursing

All Vet Nursing news

Small animal

Livestock

Equine

Exotic

Work and well-being

Opinion

Business

All Business news

Human resources

Big 6

Sustainability

Finance

Digital

Practice profiles

Practice developments

Clinical

All Clinical content

Small animal

Livestock

Equine

Exotics

Jobs

All Jobs content

All Jobs

Your ideal job

Post a job

Career Advice

Students

More

All More content

Videos

Podcasts

Digital Edition

Crossword


Terms and conditions

Complaints policy

Cookie policy

Privacy policy

fb-iconinsta-iconlinkedin-icontwitter-iconyoutube-icon

© Veterinary Business Development Ltd 2026

IPSO_regulated

Advertorial

01 February 2026

AI Masses: advancing in practice cancer triage

Sophie Duguid, diagnostics national veterinary manager at Zoetis, discusses the latest capability on the Vetscan Imagyst platform with Vet Times editor James Westgate.

sponsor_img
author_img

Vet Times

Job Title



AI Masses: advancing in practice cancer triage

At London Vet Show, Vet Times editor James Westgate sat down with Sophie Duguid, diagnostics national veterinary manager at Zoetis, to discuss the latest capability on the Vetscan Imagyst platform: AI Masses. It is the newest addition to a system that has steadily expanded since its 2020 launch, moving from AI Faecal analysis to Digital Cytology, AI Blood Smear, AI Dermatology, AI Urine Sediment, and AI Equine Faecal Egg Count (FEC) testing.

AI Masses focuses on one of the most common and clinically significant presentations in practice – the patient with a lump. As Ms Duguid explains, fine needle aspirates remain the first step in determining whether a mass is benign or potentially neoplastic.

The new AI tool provides an immediate first‑pass assessment of the sample, helping clinicians determine whether the cells present are suspicious or benign, and whether escalation to a clinical pathologist is required. The same approach applies to lymph node aspirates, supporting differentiation between inflammatory enlargement and cancerous change.

A recurring theme in the conversation is the importance of robust data and rigorous validation. Ms Duguid emphasises that Zoetis’ AI development is grounded in clinical pathology expertise, with every application benchmarked against human specialists.

In cancer detection, especially, she notes, that there are cases where a definitive call is challenging – which is why the platform is backed by a global team of clinical pathologists available to deliver expert review within hours when needed.

For practices, the benefits centre on speed, accuracy, and workflow relief. Sample preparation remains familiar, while analysis is handled by AI or seamlessly escalated to a human expert. Faster clarity supports earlier decision-making, which can translate into improved patient outcomes and reduced anxiety for owners.

Ultimately, the goal is to strengthen clinical confidence, preserve and enhance diagnostic skills, and give veterinary teams more time to focus on the work that matters most.